Konferenzen  >  Medizin & Gesundheitswesen  >  Immunologie und Allergie

Oxford Global

Featuring 30+ presentations, the event brings together over 120 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development.

Oxford Global;     Email: c.ashford@oxfordglobal.co.uk

Immuno, Immuno Oncology, Tumours, Cancer Immunotherapy, Immunotherapy

MCI Middle East LLC

With key international, regional, and national opinion leaders, this will be a truly unique platform for leaders, colleagues, and junior members to share knowledge, network and interact for the best scientific exchange and future collaborations. We hope the Conference will provide a unique platform as a knowledge base in the treatment and prevention of Allergies, Asthma, and Immunologic Disease.

Atopic dermatitis, urticaria, severe cutaneous adverse reactions (SJS and TENS), skin allergy mimics, HAE, Drug allergy, Vaccine allergy, Occupational allergy, Insect sting allergies, Autoinflammatory diseases, Immunodeficiencies, Inborn errors of immunity, Food allergy, Anaphylaxis, Oral immunotherapy, Nutrition, Allergy prevention, Dietary interventions, Severe asthma, ACOS, Eosinophil-related diseases

Fraunhofer-Institut, Universitätskrebszentrum des Universitätsklinikums Leipzig, event lab. GmbH

The Leipzig Immune ONcology (LION) Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology. The annual meeting is organized by the Fraunhofer Institute for Cell Therapy and Immunology and the University Cancer Center of the University Hospital Leipzig.

event lab. GmbH;     Tel.: [0341 308884 – 89];     Email: tbaehr@eventlab.org

Oncology, Onkologie, Zellforschung, Immuntheraphie, cancer

Onkologie,    Stammzellforschung und -therapie

Oxford Global

With new & emerging targets and drug candidates in immuno-oncology, key opinion leaders from pharmaceutical & biotech companies as well as academic & research organisations will be presenting on innovative approaches & methods for target identification & validation, such as AI-based strategies, novel checkpoint inhibitors and latest developments & case studies in cellular therapies : TILs, gamma deltas, myeloid cells.global.co.uk

Oxford Global;     Email: c.ashford@oxfordglobal.co.uk

TILs, suppressor & myeloid cells, preclinical tumour models, bispecific antibodies

University of Leipzig and the University Hospital Leipzig, event lab. GmbH

The XXIII Lipid Meeting Leipzig will held December 13-15th, 2023 at Salles de Pologne, Germany.

The Lipid Meeting Leipzig has established itself as a renowned biannual meeting addressing cutting edge clinical and translational science in all relevant areas of lipid metabolism and diseases caused by metabolic disorders. The Lipid Meeting Leipzig is attracting researchers from around the globe. The international XXIII Lipid Meeting Leipzig 2023 addresses current and emerging topics in lipid-disorders and related diseases. This year we will discuss novel and emerging therapies for lipid disorders and related vascular disease, new insights into the regulation of lipid-metabolism and the origins of obesity, aspects of vascular inflammation and its regulation, and look into early and non-canonical mechanisms of lipid disorders and vascular disease. These topics will be presented and discussed by internationally renowned experts. The Lipid Meeting is open for all physicians, scientists and students interested in the fascinating field lipid function in medicine and physiology. It brings together an international group of participants from all career levels and from various scientific and medical disciplines to present cutting-edge research in a collegial atmosphere.

event lab. GmbH;     Tel.: [0341 308884 – 89];     Email: lipidmeeting@eventlab.org

lipid metabolism, Lipidstoffwechsels, metabolic disorders, Stoffwechselstörungen, Fettstoffwechselstörungen, lipid-disorders, Gefäßerkrankungen, vascular disease

The American Association of Immunologists

Fusion Conferences

Atherosclerosis and its complications remain the primary cause of death in the industrialized world and emerging economies worldwide. Dyslipidemia constitutes a significant risk factor for the development and progression of atherosclerotic lesions but may also lead to systemic disturbances - particularly metabolic dysfunction - that also influence cellular metabolism and function.

Physiologie und Metabolismus des Menschen,    Gefäßmedizin

FomF GmbH - Forum für medizinische Fortbildung

Zertifizierte Fortbildung für ÄrztInnen der Hämatologie und Onkologie vor Ort in München & via Livestream, 05.-06.07.24. Updates & die neuesten Leitlinien. 16 CME-Punkte wurden bei der zuständigen Ärztekammer angefragt. Jetzt informieren & buchen!

Tel.: [+49 (0) 6192 47072 00];     Email: info@fomf.de

The American Association of Immunologists